
    
      In addition to the above:

        -  To asses the complete response rate after O-ESHAP.

        -  To asses the toxicity of O-ESHAP regimen

        -  To asses the stem cells mobilization capacity of O-ESHAP regimen

        -  To evaluate the final results of the whole procedure (O-ESHAP followed by high-dose
           chemotherapy and ASCT): transplant-related mortality (TRM), overall survival (OS), and
           progression free survival (PFS)

        -  To investigate the correlation between the overall response and CD20 expression by
           tumoral cells.
    
  